|
1
|
Liao LM, Vaughan TL, Corley DA, Cook MB,
Casson AG, Kamangar F, Abnet CC, Risch HA, Giffen C, Freedman ND,
et al: Nonsteroidal anti-inflammatory drug use reduces risk of
adenocarcinomas of the esophagus and esophagogastric junction in a
pooled analysis. Gastroenterology. 142:442–452.e5, quiz e22-e23.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang H, Wang W, Diao D, Cheng Y, Song Y,
Zhu K and Dang C: Ratio of metastatic to examined lymph nodes, a
helpful staging system and independent prognostic factor of
esophagogastric junction cancer. PLoS One. 8:e732382013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guo Q, Jin Z, Yuan Y, Liu R, Xu T, Wei H,
Xu X, He S, Chen S, Shi Z, et al: New mechanisms of
tumor-associated macrophages on promoting tumor progression: Recent
research advances and potential targets for tumor immunotherapy. J
Immunol Res. 2016:97209122016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matés JM, Segura JA, Alonso FJ and Márquez
J: Anticancer antioxidant regulatory functions of phytochemicals.
Curr Med Chem. 18:2315–2338. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eswar K, Venkateshbabu N, Rajeswari K and
Kandaswamy D: Dentinal tubule disinfection with 2% chlorhexidine,
garlic extract, and calcium hydroxide against Enterococcus faecalis
by using real-time polymerase chain reaction: In vitro study. J
Conserv Dent. 16:194–198. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou Y, Su J, Shi L, Liao Q and Su Q: DADS
downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling
pathway, inhibiting cell migration and invasion. Oncol Rep.
29:605–612. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yi L and Su Q: Molecular mechanisms for
the anti-cancer effects of diallyl disulfide. Food Chem Toxicol.
57:362–370. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alam M, Zubair S, Farazuddin M, Ahmad E,
Khan A, Zia Q, Malik A and Mohammad O: Development,
characterization and efficacy of niosomal diallyl disulfide in
treatment of disseminated murine candidiasis. Nanomedicine (Lond).
9:247–256. 2013. View Article : Google Scholar
|
|
9
|
Ling H, He J, Tan H, Yi L, Liu F, Ji X, Wu
Y, Hu H, Zeng X, Ai X, et al: Identification of potential targets
for differentiation in human leukemia cells induced by diallyl
disulfide. Int J Oncol. 50:697–707. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yi L, Shan J, Chen X, Li G, Li L, Tan H
and Su Q: Involvement of calreticulin in cell proliferation,
invasion and differentiation in diallyl disulfide-treated HL-60
cells. Oncol Lett. 12:1861–1867. 2016.PubMed/NCBI
|
|
11
|
Yin X, Zhang R, Feng C, Zhang J, Liu D, Xu
K, Wang X, Zhang S, Li Z, Liu X and Ma H: Diallyl disulfide induces
G2/M arrest and provokes apoptosis through p53/p21 and MEK-ERK
pathways on human squamous cell esophageal carcinoma. Oncol Rep.
32:1748–1756. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bao B, Ali S, Banerjee S, Wang Z, Logna F,
Azmi AS, Kong D, Ahmad A, Li Y, Padhye S and Sarkar FH: Curcumin
analogue CDF inhibits pancreatic tumor growth by switching on
suppressor microRNAs and attenuating EZH2 expression. Cancer Res.
Am J Cancer Res. 3:465–477. 2013.PubMed/NCBI
|
|
13
|
Han X, Yan DM, Zhao XF, Matsuura H, Ding
WG, Li P, Jiang S, Du BR, Du PG and Zhu X: GHGKHKNK octapeptide
(P-5m) inhibits metastasis of HCCLM3 cell lines via regulation of
MMP-2 expression in in vitro and in vivo studies. Molecules.
17:1357–1372. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yin X, Zhang J, Li X, Liu D, Feng C, Liang
R, Zhuang K, Cai C, Xue X, Jing F, et al: DADS suppresses human
esophageal xenograft tumors through RAF/MEK/ERK and
mitochondria-dependent pathways. Int J Mol Sci. 15:12422–12441.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leow PC, Tian Q, Ong ZY, Yang Z and Ee PL:
Antitumor activity of natural compounds, curcumin and PKF118-310,
as Wnt/β-catenin antagonists against human osteosarcoma cells.
Invest New Drugs. 28:766–782. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
El Hasasna H, Saleh A, Al Samri H,
Athamneh K, Attoub S, Arafat K, Benhalilou N, Alyan S, Viallet J,
Al Dhaheri Y, et al: Rhus coriaria suppresses angiogenesis,
metastasis and tumor growth of breast cancer through inhibition of
STAT3, NF-κB and nitric oxide pathways. Sci Rep. 6:211442016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pal HC, Sharma S, Strickland LR, Katiyar
SK, Ballestas ME, Athar M, Elmets CA and Afaq F: Fisetin inhibits
human melanoma cell invasion through promotion of mesenchymal to
epithelial transition and by targeting MAPK and NF-κB signaling
pathways. PLoS One. 9:e863382014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schulze B, Bergis D, Balermpas P, Trojan
J, Woeste G, Bechstein WO, Rödel C and Weiss C: Neoadjuvant
chemoradiation versus perioperative chemotherapy followed by
surgery in resectable adenocarcinomas of the esophagogastric
junction: A retrospective single center analysis. Oncol Lett.
7:534–540. 2014.PubMed/NCBI
|
|
19
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang J, Yang B, Xiang T, Peng W, Qiu Z,
Wan J, Zhang L, Li H, Li H and Ren G: Diallyl disulfide inhibits
growth and metastatic potential of human triple-negative breast
cancer cells through inactivation of the β-catenin signaling
pathway. Mol Nutr Food Res. 59:1063–1075. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Su B, Su J, Zeng Y, Liu F, Xia H, Ma YH,
Zhou ZG, Zhang S, Yang BM, Wu YH, et al: Diallyl disulfide
suppresses epithelial-mesenchymal transition, invasion and
proliferation by downregulation of LIMK1 in gastric cancer.
Oncotarget. 7:10498–10512. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lai KC, Hsu SC, Kuo CL, Yang JS, Ma CY, Lu
HF, Tang NY, Hsia TC, Ho HC and Chung JG: Diallyl sulfide, diallyl
disulfide, and diallyl trisulfide inhibit migration and invasion in
human colon cancer colo 205 cells through the inhibition of matrix
metalloproteinase-2, −7, and −9 expressions. Environ Toxicol.
28:479–488. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiao X, Chen B, Liu X, Liu P, Zheng G, Ye
F, Tang H and Xie X: Diallyl disulfide suppresses SRC/Ras/ERK
signaling-mediated proliferation and metastasis in human breast
cancer by up-regulating miR-34a. PLoS One. 9:e1127202014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suzuki O, Abe M, Hashimoto Y..Suzuki O,
Abe M and Hashimoto Y: Sialylation and glycosylation modulate cell
adhesion and invasion to extracellular matrix in human malignant
lymphoma: Dependency on integrin and the Rho GTPase family. Int J
Oncol Dec. 47:2091–2099. 2015. View Article : Google Scholar
|
|
25
|
Kantelhardt EJ, Vetter M, Schmidt M,
Veyret C, Augustin D, Hanf V, Meisner C, Paepke D, Schmitt M, Sweep
F, et al: Prospective evaluation of prognostic factors uPA/PAI-1 in
node-negative breast cancer: Phase III NNBC3-Europe trial (AGO,
GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×Docetaxel. BMC
Cancer. 11:1402011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong
XY, Gu Q, Yao Z and Sun BC: Promotion of hepatocellular carcinoma
metastasis through matrix metalloproteinase activation by
epithelial-mesenchymal transition regulator Twist1. J Cell Mol Med.
15:691–700. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim EY, Do SI, Hyun K, Park YL, Kim DH,
Chae SW, Sohn JH and Park CH: High expression of urokinase-type
plasminogen activator is associated with lymph node metastasis of
invasive ductal carcinoma of the breast. J Breast Cancer.
19:156–162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou G, Peng F, Zhong Y, Chen Y, Tang M
and Li D: Rhein suppresses matrix metalloproteinase production by
regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian
carcinoma cells. Int J Oncol. 50:933–941. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim YS, Kim SH, Kang JG and Ko JH:
Expression level and glycan dynamics determine the net effects of
TIMP-1 on cancer progression. BMB Rep. 45:623–628. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park HS, Kim GY, Choi IW, Kim ND, Hwang
HJ, Choi YW and Choi YH: Inhibition of matrix metalloproteinase
activities and tightening of tight junctions by diallyl disulfide
in AGS human gastric carcinoma cells. J Food Sci. 76:T105–T111.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shaked H, Hofseth LJ, Chumanevich A,
Chumanevich AA, Wang J, Wang Y, Taniguchi K, Guma M, Shenouda S,
Clevers H, et al: Chronic epithelial NF-κB activation accelerates
APC loss and intestinal tumor initiation through iNOS
up-regulation. Proc Natl Acad Sci USA. 109:pp. 14007–14012. 2012;
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guan Z, Ding C, Du Y, Zhang K, Zhu JN,
Zhang T, He D, Xu S, Wang X and Fan J: HAF drives the switch of
HIF-1α to HIF-2α by activating the NF-κB pathway, leading to
malignant behavior of T24 bladder cancer cells. Int J Oncol.
44:393–402. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Simko V, Takacova M, Debreova M, Laposova
K, Ondriskova-Panisova E, Pastorekova S, Csaderova L and Pastorek
J: Dexamethasone downregulates expression of carbonic anhydrase IX
via HIF-1α and NF-κB-dependent mechanisms. Int J Oncol.
49:1277–1288. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li X, Xu B, Moran MS, Zhao Y, Su P, Haffty
BG, Shao C and Yang Q: 53BP1 functions as a tumor suppressor in
breast cancer via the inhibition of NF-κB through miR-146a.
Carcinogenesis. 33:2593–2600. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zong H, Wang F, Fan QX and Wang LX:
Curcumin inhibits metastatic progression of breast cancer cell
through suppression of urokinase-type plasminogen activator by
NF-kappa B signaling pathways. Mol Biol Rep. 39:4803–4808. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Freise C, Ruehl M, Erben U, Neumann U,
Seehofer D, Kim KY, Trowitzsch-Kienast W, Stroh T, Zeitz M and
Somasundaram R: A hepatoprotective Lindera obtusiloba extract
suppresses growth and attenuates insulin like growth factor-1
receptor signaling and NF-kappaB activity in human liver cancer
cell lines. BMC Complement Altern Med. 11:392011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tian F, Ding D and Li D: Fangchinoline
targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901
cells. Int J Oncol. 46:2355–2363. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Miao X and Zhao Y: ST6GalNAcII mediates
tumor invasion through PI3K/Akt/NF-κB signaling pathway in
follicular thyroid carcinoma. Oncol Rep. 35:2131–2140. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang G, Liu G, Ye Y, Fu Y and Zhang X:
Upregulation of miR-34a by diallyl disulfide suppresses invasion
and induces apoptosis in SGC-7901 cells through inhibition of the
PI3K/Akt signaling pathway. Oncol Lett. 11:2661–2667.
2016.PubMed/NCBI
|
